Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration

Published:2016-08 Issue:8 Volume:123 Page:1751-1761
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Maguire Maureen G.,Martin Daniel F.,Ying Gui-shuang,Jaffe Glenn J.,Daniel Ebenezer,Grunwald Juan E.,Toth Cynthia A.,Ferris Frederick L.,Fine Stuart L.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference40 articles.

1. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

2. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

3. Optical coherence tomography after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration;Rosenfeld;Ophthalmic Surg Lasers Imaging,2005

4. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration;Avery;Ophthalmology,2006

5. Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration;Curtis;Arch Ophthalmol,2010

Cited by 557 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-year efficacy and safety of different anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: a network meta-analysis of randomized controlled trials;Eye;2024-09-11

2. Visual and Anatomic Responses in Patients With Neovascular Age-Related Macular Degeneration and a Suboptimal Response to Anti-VEGF Therapy Switched to Faricimab;Journal of VitreoRetinal Diseases;2024-08-31

3. AI-based methods for detecting and classifying age-related macular degeneration: a comprehensive review;Artificial Intelligence Review;2024-08-07

4. Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular Degeneration;Ophthalmology Retina;2024-08

5. Recent Updates on the Diagnosis and Management of Age-Related Macular Degeneration;Mayo Clinic Proceedings: Innovations, Quality & Outcomes;2024-08